We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
TheDogApp connects a community of Dog Owners via a new exciting social media app. Dog owners are able to interact with other dog owners, find local experts/dog services and share pictures and videos. TheDogApp is a Facebook/Instagram for dog owners, capitalising on social media applications that focus on a person's hobby or passion. 
days to go: Expired investment: £400,000
VoxSmart is a global mobile technology company focused on achieving compliance in a very heavy regulated industries such as finance and banking. VoxSmart software is embedded on the mobile device and allows the capturing and recording of all communications on that device
days to go: Expired investment: £3,857,500
A cyber-defence system preventing criminals accessing secure information from internet-enabled businesses. vzInternet Limited have developed Assayer, a cloaking tool that works differently to traditional cybersecurity systems. Assayer aims to tackle criminal behaviour by removing the time they have to exploit an organisation, rather than current methods that only add more layers for criminals to break through. vzInternet Limited is in the process of creating three version of their Assayer range, targeted for specific needs. Assayer Freedom is the initial offering that will prevent criminals from using stolen information and biometric data to access private material. Assayer Trust aims to tackle malware designed to convince customers to provide personal information and Assayer Veto is being created to protect businesses from internal attacks by employees and third-party contractors.
days to go: Expired investment: £60,000
whatimpact is a social impact technology entity that uses AI and specific reporting tools to match charities and social enterprises, termed 'Recipients', with donor companies and grant-makers, termed 'Supporters' to ensure efficiency and transparency in Corporate Social Responsibility (CSR) and grant-making. whatimpact aspires to become a contender in the CSR segment that is estimated to be worth over £76 billion in reputational value to UK corporates. The business has onboarded 20 companies and 120 charities/Social Enterprises in Q1 2021 including EY, Brewin Dolphin, and Engie. whatimpact has a further 500 charities/social enterprises and 45 corporates in the pipeline. Its subscriptions range from £100/month to £2,000/month. It will use the investment to develop its algorithm and datasets, engage in customer acquisition, and build its leadership team.
days to go: Expired investment: £375,002
Wise Analytics Group uses data to help companies, consumers and brands make better connections and more benefitial choices. They are a leader in terms of media analytics in the beauty sector, using a range of tools, technology and experience to create a product, market and consumer insight. Wise Analytics group have clients such as L'Oreal and Estee lauder. They are now looking to expand into other locations. 
days to go: Expired investment: Withheld
Zap and Go have created ultra fast technology for cordless and hand held devices by using Carbon-Ion technology which result in ultra-fast charging, taking 5 minutes or less. The technology is part derived from Oxford University and in part developed independently by Zap&Go's own scientists.   
days to go: Expired investment: £1,353,551
Zentraxa is focused on precision bioengineering to produce peptides with predictable properties tailored towards purpose. The company points out that peptides are amino acids that are the building blocks of certain proteins needed by the skin, like collagen and elastin. It has come out with a synthetic biology platform, Zentide, that designs, produces and tests novel peptides. Zentraxa argues that Zentide can circumvent previously existing bio-design limits imposed by conventional peptide synthesis and produce tailor-made biomaterials for healthcare, personal care and industrial uses. Zentraxa is initially targeting healthcare with its first biomaterial, a debondable adhesive, for use in wound care. The company asserts that the material has other uses such as cosmetics and industrial applications due to its ability to bond strongly while still being easily and painlessly removable. Zentraxa will use the investment to create a portfolio of other biomaterials for licensing to global businesses in the health and industrial sectors via its Zentide platform. 
days to go: Expired investment: £1,040,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph